# Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy

> **NCT01666782** · PHASE2 · COMPLETED · sponsor: **Saad Jamshed MD** · enrollment: 105 (actual)

## Conditions studied

- Cancer
- Influenza Viral Infections

## Interventions

- **BIOLOGICAL:** Standard Trivalent Influenza Vaccine
- **BIOLOGICAL:** High-Dose Influenza Vaccine

## Key facts

- **NCT ID:** NCT01666782
- **Lead sponsor:** Saad Jamshed MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2015-06
- **Final completion:** 2015-12
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2016-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01666782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01666782, "Study Comparing High-Dose Flu Vaccine to Standard Vaccine in Cancer Patients Less Than 65 Receiving Chemotherapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01666782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*